BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)

BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD)

No trades
See on Supercharts

Price target

68.630.000.00%
The 4 analysts offering 1 year price forecasts for 0QNA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to 0QNA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0QNA EPS for the last quarter is 1.61 CHF despite the estimation of 1.17 CHF. In the next quarter EPS is expected to reach 3.24 CHF. Track more of BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) financials and stay on top of what is up with the company.
In the next quarter BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) revenue is expected to reach ‪128.90 M‬ CHF. Check out BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) revenue and earnings and make informed decisions.
According to analysts, 0QNA price target is 68.63 CHF with a max estimate of 100.00 CHF and a min estimate of 52.00 CHF. Check if this forecast comes true in a year, meanwhile watch BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) stock price chart and keep track of the current situation with 0QNA news and stock market news.